Ixabepilone is an epothilone B analog developed by Bristol-Myers Squibb as a
chemotherapeutic medication for cancer. It is produced by Sorangium cellulosum
Learn about IXEMPRA® (ixabepilone), including safety and boxed warning, side
effects, benefits and risks, and dosing information.
On October 16, 2007, the U.S. Food and Drug Administration (FDA) approved
ixabepilone for injection (Ixempra™, made by Bristol-Myers Squibb) for the ...
Ixabepilone is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug.
Ixabepilone is classified as an "antimicrotubule agent" or an "epothilone B ...
Nov 15, 2007 ... This page contains brief information about ixabepilone and a collection of links to
more information about the use of this drug, research results, ...
Generic Name: Ixabepilone Ixempra is the trade name for the generic
chemotherapy drug Ixabepilone. In some cases, health care professionals may
use the ...
Ixabepilone is an analogue of natural epothilone B with activity against a wide
range of tumor types, including drug-resistant tumors. This is consistent with the ...
Ixempra (ixabepilone): For the treatment of breast cancer. New approved drug
details including side effects, uses and general information.
Learn about ixabepilone and its possible side effects. Used for breast cancer
treatment, ixabepilone is given intravenously and works by destroying cancer
Learn about Ixempra (Ixabepilone) may treat, uses, dosage, side effects, drug
interactions, warnings, patient labeling, reviews, and related medications.